ARTICLES BY LOUIS

• Diesels To Drugs: What Trucks Teach Pharma About Quality And Leadership

  12/1/2014

  Mikael Ericson worked for Scania, the renowned global leader in the manufacture of heavy trucks and buses. That, for him, logically led to a 12-year career at AstraZeneca. Which, with a more intuitive logic, led to his September appointment as CEO at Kemwell AB, the Swedish arm of the India-based contract development and manufacturing organization.

• At Global Forum, Pharma Outsourcing Stakeholders Reveal Some Truths

  11/21/2014

  The stage was the Outsourced Pharma West conference in the Hyatt Regency in San Francisco. Some of the discussion swirled around big pharma’s full-scale incursion into China, perhaps for some unexpected reasons, and the contemplation of wringing “some risk” out of an India dependency. 

• Outsourced Pharma West Participants Question One-Stop-Shop Model

  11/17/2014

  The industry trend of the “One-Stop-Shop” biopharmaceutical service provider took a rhetorical hit at the inaugural Outsourced Pharma West conference.  Executives from Merck, Pfizer and AZ mentioned they didn’t believe the concept could work and were not sure why it was so much in vogue. 

• Dow Assists Drug Delivery With Excipients And Outsourcing

  11/14/2014

  Dow Pharma & Food Solutions (DP&FS) has focused intently on improving a specific area of the pharmaceutical industry: solubility, and thus bioavailability, in new and existing drugs. In Dow’s advancement and supplying of polymers as excipients, it works hand-in-hand with outsourcing service providers. But don’t call Dow itself a provider.

• WuXi Historic Company In Pharma Outsourcing

  11/3/2014

  Hard to argue with the categorical proposition that no single entity has fundamentally influenced the growth and shape of global pharma outsourcing as has WuXi of Shanghai. What has been debated is the nature of that impact on the industry. I sat down with Todd D. Nelson, Ph.D., VP of Operations, Alliance Management and Business Development, WuXi STA, to discuss.

• Pharma Asks: Who Manages What At Advancing Service Providers?

  10/27/2014

  Antonio Magnelli has a new SVP role in Europe. Patheon and all stripes and sizes of pharma providers are on the move. Like sharks, stop swimming and they won’t survive. Sponsors need to pay attention to changing leadership positions as well as to who is managing their projects at their outsourcing partners. 

• An Antibody Drug Conjugate In Every Garage

  10/22/2014

  The conference took on an old-time carnival atmosphere. At the end of one long day, I imagine a barker with megaphone among the booths: “Step right up. Get your very own look at an antibody drug conjugate platform. Don’t be the last in your neighborhood without an ADC in your garage.” Or maybe it was “in your pipeline.” It definitely was ADCs, though.

• Brand Equity Lessons At CPhI Worldwide From “Rx India”

  10/16/2014

  Six exhibition halls in Paris Nord Villepinte, France, encased city-like ecosystems (or gigantic beehives); the conference in total so big it was hard to plan a strategy. It was a battle of outsourcing provider brands, and differentiation was difficult.

• A Global Forum For Outsourcing (With Simple Objectives)

  9/24/2014

  Perhaps the best advice I’ve heard regarding industry conferences is twofold: first, make sure you attend, and second, keep your objectives for attending simple.

• Serial Entrepreneur Points To Initial Funding Sources For Biotechs

  9/24/2014

  Kevin Judice lists himself on LinkedIn as “Entrepreneur.” Perhaps he has to; there just isn’t enough space to include the three companies he recently started and at which he concurrently is employed as CEO or CSO.